{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T13:54:49Z","timestamp":1781963689683,"version":"3.54.5"},"reference-count":50,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T00:00:00Z","timestamp":1490918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100005634","name":"Suomen Hammasl\u00e4\u00e4k\u00e4riseura Apollonia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004092","name":"Kuopion Yliopistollinen Sairaala","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004092","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Diseases"],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To carry out a double\u2010blind randomized controlled trial (<jats:styled-content style=\"fixed-case\">RCT<\/jats:styled-content>) to compare the effectiveness of topical tacrolimus (<jats:styled-content style=\"fixed-case\">TAC<\/jats:styled-content>), triamcinolone acetonide (<jats:styled-content style=\"fixed-case\">TRI<\/jats:styled-content>), and placebo (<jats:styled-content style=\"fixed-case\">PLA<\/jats:styled-content>) in symptomatic oral lichen planus (<jats:styled-content style=\"fixed-case\">OLP<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Subjects and Methods<\/jats:title><jats:p>A clinical score (<jats:styled-content style=\"fixed-case\">CS<\/jats:styled-content>, range 0\u2013130) was developed to measure the clinical signs and symptoms of <jats:styled-content style=\"fixed-case\">OLP<\/jats:styled-content>. Twenty\u2010seven <jats:styled-content style=\"fixed-case\">OLP<\/jats:styled-content> patients with a <jats:styled-content style=\"fixed-case\">CS<\/jats:styled-content> of \u226520 were randomly allocated to receive 0.1% <jats:styled-content style=\"fixed-case\">TAC<\/jats:styled-content> ointment (<jats:italic>n<\/jats:italic>\u00a0=\u00a011), 0.1% <jats:styled-content style=\"fixed-case\">TRI<\/jats:styled-content> paste (<jats:italic>n<\/jats:italic>\u00a0=\u00a07), or Orabase<jats:sup>\u00ae<\/jats:sup> paste as <jats:styled-content style=\"fixed-case\">PLA<\/jats:styled-content> (<jats:italic>n<\/jats:italic>\u00a0=\u00a09) for 3\u00a0weeks. If the <jats:styled-content style=\"fixed-case\">CS<\/jats:styled-content> dropped \u226520% (interpreted as response), the patients continued the same medication for another 3\u00a0weeks. If the <jats:styled-content style=\"fixed-case\">CS<\/jats:styled-content> dropped &lt;20% or increased (non\u2010response), the patients were switched to <jats:styled-content style=\"fixed-case\">TAC<\/jats:styled-content> for 6\u00a0weeks. A 6\u2010month follow\u2010up period ensued. The primary outcome variable was the change in <jats:styled-content style=\"fixed-case\">CS<\/jats:styled-content> from baseline to week 3. In primary outcome analysis, <jats:styled-content style=\"fixed-case\">CS<\/jats:styled-content> values between the treatment arms were compared.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Tacrolimus and <jats:styled-content style=\"fixed-case\">TRI<\/jats:styled-content> were more effective (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.012 and 0.031, respectively) than <jats:styled-content style=\"fixed-case\">PLA<\/jats:styled-content> in reducing the <jats:styled-content style=\"fixed-case\">CS<\/jats:styled-content> at week 3. No difference in the efficacy was noted between <jats:styled-content style=\"fixed-case\">TAC<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">TRI<\/jats:styled-content> (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.997).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This pilot <jats:styled-content style=\"fixed-case\">RCT<\/jats:styled-content> provides evidence for the effectiveness of <jats:styled-content style=\"fixed-case\">TAC<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">TRI<\/jats:styled-content> over <jats:styled-content style=\"fixed-case\">PLA<\/jats:styled-content> in the management of <jats:styled-content style=\"fixed-case\">OLP<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/odi.12653","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T04:02:47Z","timestamp":1486440167000},"page":"660-668","source":"Crossref","is-referenced-by-count":31,"title":["Topical tacrolimus, triamcinolone acetonide, and placebo in oral lichen planus: a pilot randomized controlled trial"],"prefix":"10.1111","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2357-830X","authenticated-orcid":false,"given":"M","family":"Siponen","sequence":"first","affiliation":[{"name":"Institute of Dentistry University of Oulu Oulu Finland"},{"name":"Cancer and Translational Medicine Research Unit University of Oulu Oulu Finland"},{"name":"Department of Oral and Maxillofacial Diseases Kuopio University Hospital Kuopio Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Huuskonen","sequence":"additional","affiliation":[{"name":"Institute of Dentistry University of Oulu Oulu Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kallio\u2010Pulkkinen","sequence":"additional","affiliation":[{"name":"Institute of Dentistry University of Oulu Oulu Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Nieminen","sequence":"additional","affiliation":[{"name":"Medical Informatics and Statistics Research Group University of Oulu Oulu Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Salo","sequence":"additional","affiliation":[{"name":"Institute of Dentistry University of Oulu Oulu Finland"},{"name":"Cancer and Translational Medicine Research Unit University of Oulu Oulu Finland"},{"name":"Department of Oral and Maxillofacial Diseases University of Helsinki Helsinki Finland"},{"name":"Medical Research Center Oulu University Hospital Oulu Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,3,31]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"99","article-title":"The comparison of efficacy of adcortyl ointment and topical tacrolimus in treatment of erosive oral lichen planus","volume":"1","author":"Azizi A","year":"2007","journal-title":"J Dent Res Dent Clin Dent Prospects"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-7"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.1999.tb00063.x"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2007.06.022"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000118"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2010.07.014"},{"key":"e_1_2_8_8_1","volume-title":"Statistical power analysis for the behavioral sciences","author":"Cohen J","year":"1988"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2007.01191.x"},{"issue":"7","key":"e_1_2_8_10_1","first-page":"CD009864","article-title":"Topical tacrolimus for atopic dermatitis","author":"Cury Martins J","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120452"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08106.x"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.3758\/BF03193146"},{"key":"e_1_2_8_14_1","first-page":"133","article-title":"Pain measurement tools for clinical practice and research","volume":"64","author":"Flaherty SA","year":"1996","journal-title":"AANA J"},{"key":"e_1_2_8_15_1","unstructured":"Food and Drug Administration(2006).Information for healthcare professionals: tacrolimus (marketed as Protopic). U.S Food & Drug Administration Web site. Available from:https:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm126497.htm. Published June 2006. Last updated Aug 13 2013 (accessed 25 May 2016)."},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199512000-00008"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/jicd.12237"},{"key":"e_1_2_8_18_1","first-page":"466","article-title":"Long\u2010term efficacy and safety of topical tacrolimus in the management of ulcerative\/erosive oral lichen planus","volume":"13","author":"Hodgson T","year":"2003","journal-title":"Eur J Dermatol"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2005.01221.x"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120535"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2015.27.5.485"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0070"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.02.1116"},{"key":"e_1_2_8_24_1","first-page":"419","article-title":"Successful treatment of erosive lichen planus with topical tacrolimus","volume":"137","author":"Lener EV","year":"2001","journal-title":"Arch Dermatol"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2009.04271.x"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2009.00830.x"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2006.02.033"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2010.02.030"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2008.00662.x"},{"key":"e_1_2_8_30_1","first-page":"15","article-title":"Measurement of subjective phenomena in primary care research: the Visual Analogue Scale","volume":"13","author":"Miller MD","year":"1993","journal-title":"Family Pract Res J"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10266-016-0255-4"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.126275"},{"issue":"64","key":"e_1_2_8_33_1","first-page":"23","article-title":"Topical tacrolimus for the treatment of recalcitrant oral lichen planus \u2010a double\u2010blind comparison study. British Association of Dermatologists 83rd Annual Meeting. Abstract P\u201012","volume":"149","author":"Narayan S","year":"2003","journal-title":"Br J Dermatol"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.10.1335"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06899.x"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-60592-5"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2007.07.029"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10011-1311"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12758"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.119648"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02168.x"},{"key":"e_1_2_8_42_1","unstructured":"SiponenM SaloT(2008).A clinical score for oral lichen planus.14th International Congress International Association of Oral Pathologists & 62nd Annual Meeting American Academy of Oral & Maxillofacial Pathology Joint Conference San Francisco CA USA. Abstract 120. Conference publication: 74."},{"issue":"1","key":"e_1_2_8_43_1","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.4103\/0975-7406.191976","article-title":"A randomized triple\u2010blind clinical trial to compare the effectiveness of topical triamcinolone acetonate (0.1%), clobetasol propionate (0.05%), and tacrolimus orabase (0.03%) in the management of oral lichen planus","volume":"8","author":"Sivaraman S","year":"2016","journal-title":"J Pharm Bioallied Sci"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2012.05459.x"},{"issue":"7","key":"e_1_2_8_45_1","first-page":"CD001168","article-title":"Interventions for treating oral lichen planus","author":"Thongprasom K","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/jop.12083"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1977.tb05211.x"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08974.x"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02672.x"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(93)90091-H"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.4317\/medoral.20524"}],"container-title":["Oral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fodi.12653","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/odi.12653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T14:27:29Z","timestamp":1696256849000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/odi.12653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,31]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1111\/odi.12653"],"URL":"https:\/\/doi.org\/10.1111\/odi.12653","archive":["Portico"],"relation":{},"ISSN":["1354-523X","1601-0825"],"issn-type":[{"value":"1354-523X","type":"print"},{"value":"1601-0825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,31]]}}}